Literature DB >> 7129629

Arousal of mucosal secretory immunoglobulin A antitoxin in rats immunized with Escherichia coli heat-labile enterotoxin.

F A Klipstein, R F Engert, J D Clements.   

Abstract

Specific serum and mucosal antitoxin levels were determined by enzyme-linked immunosorbent assays in rats immunized with Escherichia coli heat-labile enterotoxin (LT). Immunization by means of a parenteral prime followed by peroral boosts was the only approach that aroused titers of both serum immunoglobulin G (IgG) antitoxin and mucosal secretory IgA antitoxin that were increased fourfold or more over control values. Primary parenteral immunization was effective when given either intraperitoneally or subcutaneously with either Freund complete adjuvant or alum as the adjuvant. The magnitude of the nucosal secretory IgA antitoxin response and the degree of protection against challenge with either LT or viable LT-producing organisms were related to the number and dosage of peroral boosts. LT antigenicity, as determined by enzyme-linked immunosorbent assay, was progressively reduced by toxoiding it with increasing amounts of glutaraldehyde or a carbodiimide; when LT antigenicity was reduced by greater than 50%, the effectiveness of the toxoid in stimulating mucosal antitoxin and providing protection was compromised. Strong protection extended for more than 6 weeks only in rats immunized with a sufficient peroral dosage of LT to arouse mucosal secretory IgA antitoxin titers at least fourfold greater than those of controls. These observations indicate that the ability of LT to stimulate a mucosal secretory IgA antitoxin response is dependent on the antigenicity, route, and dosage of this immunogen; they suggest that the duration of protection in animals immunized by the peroral route is related to the extent of arousal of mucosal secretory IgA antitoxin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7129629      PMCID: PMC347652          DOI: 10.1128/iai.37.3.1086-1092.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Priming and suppression of the intestinal immune response to cholera toxoid/toxin by parenteral toxoid in rats.

Authors:  N F Pierce; F T Koster
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

2.  Influence of route of administration on immediate and extended protection in rats immunized with Escherichia coli heart-labile enterotoxin.

Authors:  F A Klipstein; R F Engert
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

3.  Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures.

Authors:  J D Clements; R A Finkelstein
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

4.  Antitoxic immunity to cholera in dogs immunized orally with cholera toxin.

Authors:  N F Pierce; W C Cray; P F Engel
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

5.  Protective effect of immunization with heat-labile enterotoxin in gnotobiotic rats monocontaminated with enterotoxigenic Escherichia coli.

Authors:  F A Klipstein; R F Engert; H B Short
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

6.  Special features of the priming process for a secretory IgA response. B cell priming with cholera toxin.

Authors:  J A Fuhrman; J J Cebra
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

7.  Protection in rats immunized with Escherichia coli heat-stable enterotoxin.

Authors:  F A Klipstein; R F Engert; J D Clements
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

8.  Respective contributions to protection of primary and booster immunization with Escherichia coli heat-labile enterotoxin in rats.

Authors:  F A Klipstein; R F Engert
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

9.  Protective effect of immunization of rats with holotoxin or B subunit of Escherichia coli heat-labile enterotoxin.

Authors:  F A Klipstein; R F Engert
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

10.  Immunization of rats with heat-labile enterotoxin provides uniform protection against heterologous serotypes of enterotoxigenic Escherichia coli.

Authors:  F A Klipstein; R F Engert; J D Clements
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

View more
  16 in total

Review 1.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines.

Authors:  A B Hartman; L L Van de Verg; H H Collins; D B Tang; N O Bendiuk; D N Taylor; C J Powell
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

3.  Surface antigens of Obeliscoides cuniculi inducing local and systemic humoral responses in infected rabbits.

Authors:  H Wedrychowicz; E Sinski; B Bezubik
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

4.  Peroral immunization of rats with Escherichia coli heat-labile enterotoxin delivered by microspheres.

Authors:  F A Klipstein; R F Engert; W T Sherman
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

5.  Induction of optimal mucosal antibody responses: effects of age, immunization route(s), and dosing schedule in rats.

Authors:  N F Pierce
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

6.  Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice.

Authors:  P J Van der Heijden; A T Bianchi; M Dol; J W Pals; W Stok; B A Bokhout
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

7.  Combined parenteral and oral immunization results in an enhanced mucosal immunoglobulin A response to Shigella flexneri.

Authors:  D F Keren; R A McDonald; J L Carey
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

8.  Effect of parenteral immunization on the intestinal immune response to Salmonella typhi Ty21a.

Authors:  B D Forrest; J T LaBrooy; C E Dearlove; D J Shearman
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

9.  Properties of synthetically produced Escherichia coli heat-stable enterotoxin.

Authors:  F A Klipstein; R F Engert; R A Houghten
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

10.  Effect of parenteral immunization on the local immunoglobulin A response of the intestine to Shigella flexneri antigens.

Authors:  D F Keren; P J Scott; R A McDonald; M Wiatrak
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.